- Home
- MYNZ vs SINT Comparison
MYNZ vs SINT Comparison
Compare MYNZ & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYNZ
- SINT
- Stock Information
- Founded
- MYNZ 2021
- SINT 1996
- Country
- MYNZ Germany
- SINT United States
- Employees
- MYNZ N/A
- SINT N/A
- Industry
- MYNZ Biotechnology: Pharmaceutical Preparations
- SINT Medical/Dental Instruments
- Sector
- MYNZ Health Care
- SINT Health Care
- Exchange
- MYNZ Nasdaq
- SINT Nasdaq
- Market Cap
- MYNZ 7.6M
- SINT 7.9M
- IPO Year
- MYNZ 2021
- SINT 2014
- Fundamental
- Price
- MYNZ $2.04
- SINT $2.80
- Analyst Decision
- MYNZ Buy
- SINT Strong Buy
- Analyst Count
- MYNZ 2
- SINT 1
- Target Price
- MYNZ $14.00
- SINT $28.00
- AVG Volume (30 Days)
- MYNZ 185.7K
- SINT 231.7K
- Earning Date
- MYNZ 08-05-2025
- SINT 08-12-2025
- Dividend Yield
- MYNZ N/A
- SINT N/A
- EPS Growth
- MYNZ N/A
- SINT N/A
- EPS
- MYNZ N/A
- SINT N/A
- Revenue
- MYNZ $893,991.00
- SINT $2,569,000.00
- Revenue This Year
- MYNZ $26.06
- SINT N/A
- Revenue Next Year
- MYNZ $4.97
- SINT $87.50
- P/E Ratio
- MYNZ N/A
- SINT N/A
- Revenue Growth
- MYNZ N/A
- SINT N/A
- 52 Week Low
- MYNZ $1.34
- SINT $1.71
- 52 Week High
- MYNZ $19.00
- SINT $8.60
- Technical
- Relative Strength Index (RSI)
- MYNZ 57.11
- SINT 42.97
- Support Level
- MYNZ $1.89
- SINT $2.52
- Resistance Level
- MYNZ $2.25
- SINT $2.94
- Average True Range (ATR)
- MYNZ 0.22
- SINT 0.19
- MACD
- MYNZ 0.05
- SINT -0.05
- Stochastic Oscillator
- MYNZ 76.14
- SINT 29.09
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.
About SINT SiNtx Technologies Inc.
SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.